NYU Langone Health (New York, NY) is hosting a virtual conference for doctors and nurses on the topic of inflammation and cardiovascular disease. The conference is free for registrants from certain countries outside the US. Registered participants will have access to the course recording for an additional 30 days after the meeting, providing an opportunity for asynchronous learning. Hot topics include: biologics for pericarditis, colchicine for cardiovascular disease prevention and cardiovascular disease risk in South Asian populations.
Cardiometabolic Risk in Inflammatory Conditions: Emerging Insights and Treatment of Inflammation in Cardiovascular Disease
Friday, April 29, 2022
Link to register: nyulmc.org/cvinflammationcme
Code for Free Registration (Taiwan): cardiometawaived22
Cardiometabolic Risk in Inflammatory Conditions - April 29, 2022
|
|
|
Continuing Medical Education
|
|
|
|
|
|
|
2nd Annual Cardiometabolic Risk in Inflammatory Conditions: Emerging Insights and Treatment of Inflammation in Cardiovascular Disease
|
|
|
|
|
|
|
Virtual Webinar - April 29, 2022
|
|
This half-day course will cover state-of-the-art topics on the management of patients at elevated risk of cardiovascular and cardiometabolic disease due to underlying systemic inflammation. This course is designed to provide an informative and practical guide towards the clinical management of cardiovascular disease in patients with systemic inflammation including those with recurrent pericarditis, dyslipidemia, and elevated genetic cardiovascular risk. The course is meant to be an update on recent data linking systemic inflammation and cardiovascular disease including reviewing such landmark trials as the CANTOS trial, those related to colchicine, and upcoming clinical trials in cardiology targeting the immune system. Data and clinical pearls will be presented on the use of immune-modulating therapies (including newly FDA-approved therapies) in pericarditis. Finally, a series of speakers will discuss emerging data linking systemic inflammation with high cardiovascular risk patient populations including those with a strong family history of heart disease and the relationship between dyslipidemia and inflammation. Question and Answer sessions will be spread throughout the day to encourage interaction and audience participation with interspersed panel discussions from experts describing their own experiences, practical approaches, and lessons learned from cardio-inflammatory clinics.
|
|
|
|
|
|
|
|
|
|
|
|
Michael S. Garshick, MD
Assistant Professor of Medicine
NYU Grossman School of Medicine
Cardio-Rheumatology Program
Center for the Prevention of Cardiovascular Disease
New York, NY
Nehal N. Mehta, MD, MSCE, FAHA
Lasker Senior Investigator
Chief, Lab of Inflammation and Cardiometabolic Diseases
National Heart, Lung and Blood Institute
Bethesda, MD
|
|
|
|
|
Hear Clinical Experts Speak on These Hot Topics and More!
|
- Systemic Inflammation, What it is, and How do we get it?
- Biologics for the Treatment of Pericarditis
- CV Risk in the South Asian Population: Is Inflammation the Answer?
- Adding Colchicine for Cardiovascular Prevention...Is it time?
- Lipids and Inflammation
- Practical Lessons from CardioInflammatory Clinics: Cases and
Discussion
|
|
|
|
|
|
|
|
|
